Question 1

What does Sai Parenteral’s Limited do?

Accepted Answer

Sai Parenterals Limited develops and manufactures a diversified portfolio of 302 pharmaceutical products spanning chronic, sub-chronic, and acute therapeutic areas, earning revenue through domestic and international product sales. Price band ₹372.00-₹392.00; issue size ₹285.00 cr.

Question 2

When does the Sai Parenteral’s Limited IPO open and close?

Accepted Answer

The Sai Parenteral’s Limited IPO opens for subscription on March 24, 2026 and closes on March 27, 2026. Shares are expected to list on April 2, 2026.

Question 3

What is the issue price of the Sai Parenteral’s Limited IPO?

Accepted Answer

The Sai Parenteral’s Limited IPO was priced at ₹392 per equity share.

Question 4

What is the lot size for the Sai Parenteral’s Limited IPO?

Accepted Answer

The lot size is 38 equity shares. At ₹392 per share, one lot requires ₹14,896.

Question 5

What is the issue size of the Sai Parenteral’s Limited IPO?

Accepted Answer

The total issue size is ₹408.79 crore. This comprises a fresh issue of ₹285.00 crore, which the company receives, and an offer for sale of ₹123.79 crore, which goes to selling shareholders.

Question 6

How did Sai Parenteral’s Limited perform on listing?

Accepted Answer

Sai Parenteral’s Limited opened at ₹400 against an issue price of ₹392, a premium of 2.04% on debut.

Question 7

Who are the lead managers for the Sai Parenteral’s Limited IPO?

Accepted Answer

The book running lead managers are Arihant Capital Markets Limited. The registrar to the issue is Bigshare Services Private Limited.

Sai Parenteral’s Limited

Issue Timeline & Lifecycle

Subscription Demand

Fundamentals & Key Metrics

Valuation & Multiples

Profitability & Returns

Financial Health & Solvency

Financials at a glance

Shareholding, Ownership & Dilution

AI Summary

Prospectus Research

Issue intermediaries

Official Prospectus Filings

Frequently Asked Questions